Prime Medicine, Inc.
Income Statement
| Line Item | Jul 2025 | Jun 2025 | Apr 2025 | Mar 2025 | Feb 2025 | Dec 2024 | Oct 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $1.1M | — | $1.5M | — | — | — | $209.0K |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | $41.4M | — | $40.6M | — | — | — | $40.3M |
| SG&A Expense | — | $13.1M | — | $13.3M | — | — | — | $14.1M |
| Operating Income | — | $-53.4M | — | $-52.4M | — | — | — | $-54.2M |
| Operating Margin | — | -4,787.2% | — | -3,603.3% | — | — | — | -25,948.3% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | — | — | — | — | — | — | — | — |
| Income Tax Expense | — | $0 | — | $0 | — | — | — | $0 |
| Net Income | — | $-52.6M | — | $-51.9M | — | — | — | $-52.5M |
| Net Margin | — | -4,716.7% | — | -3,568.8% | — | — | — | -25,128.2% |
| EPS (Basic) | — | $-0.41 | — | $-0.40 | — | — | — | $-0.44 |
| EPS (Diluted) | — | $-0.41 | — | $-0.40 | — | — | — | $-0.44 |
| Shares Outstanding (Basic) | 134.6M | 129.2M | 131.3M | 130.9M | 131.2M | 131.2M | 131.2M | 119.8M |
| Shares Outstanding (Diluted) | 134.6M | 129.2M | 131.3M | 130.9M | 131.2M | 131.2M | 131.2M | 119.8M |
| Dividends Per Share | — | — | — | — | — | — | — | — |
Find something you enjoy doing and give it everything you've got, and the money will take care of itself.